查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
炎症性腸病治療市場規模、份額和趨勢分析報告，按類型（克羅恩病、潰瘍性結腸炎）、藥物類別、給藥途徑、分銷渠道、地區、分部預測，2023-2030 年
市場調查報告書
商品編碼
1233140

炎症性腸病治療市場規模、份額和趨勢分析報告，按類型（克羅恩病、潰瘍性結腸炎）、藥物類別、給藥途徑、分銷渠道、地區、分部預測，2023-2030 年

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

炎症性腸病治療市場的增長和趨勢

Grand View Research, Inc. 的一份新報告預測，全球炎症性腸病治療市場將達到 270 億美元，從 2023 年到 2030 年，複合年增長率為 3.6%。我來了。

患病率上升、人們對炎症性腸病的認識激增以及有利的監管環境預計將在預測期內推動炎症性腸病治療市場。 例如，2022 年 12 月，輝瑞公司宣布美國 FDA 接受了依曲莫德用於嚴重潰瘍性結腸炎患者的 NDA。 用於治療炎症性腸病的治療指定和批准新藥的有利監管舉措正在推動市場擴張。

市場參與者和非營利組織之間加強合作以應對開發治療 IBD 的新療法方面的各種挑戰，預計這將推動市場增長。 例如，2022 年 10 月，精準醫療公司 Verily 與克羅恩病和結腸炎基金會擴大了戰略合作，以加速潰瘍性結腸炎和克羅恩病的研究。 此外，歐洲克羅恩病和結腸炎組織已採取多項有利措施來改善炎症性腸病患者的護理。

filgotinib、ozanimod、upadacitinib 和 risankizumab 等新藥最近獲批用於治療炎症性腸病，預計將支持未來幾年的市場增長。 此外，監管機構正在推動製造商開發針對罕見和危及生命的疾病的新型治療方法。 例如，2020 年 12 月，Thetis Pharmaceuticals 獲得了美國 FDA 授予的 TP-317孤兒藥指定，用於治療小兒潰瘍性結腸炎。 預計此類有利可圖的舉措將促進研發活動，以開發針對 IBD 的新型治療產品。

此外，用於治療各種炎症性疾病的生物仿製藥的需求和批准不斷增加是市場的一個重要影響因素。 例如，2022年12月，美國FDA批准Idacio作為美國第8個阿達木單抗生物類似藥。 新批准的生物仿製藥是一種低濃度、無檸檬酸鹽的製劑，用於治療成人和 6 歲及以上兒童的多種炎症性疾病，包括 CD。 此外，2021 年 10 月，美國 FDA 批准 Cyltezo 用於治療中度至重度 CD 和 UC。 此外，越來越多地採用生物仿製藥預計將推動新興經濟體採用生物製劑治療 IBD。

此外，政府機構正在努力促進生物仿製藥的安全使用。 例如，2022 年 10 月，薩斯喀徹溫省政府啟動了一項生物仿製藥計劃，讓居民能夠以更低的成本獲得高質量的藥物。 同樣，加拿大安大略省和魁北克省等省正在擴大生物仿製藥計劃，以促進候選生物仿製藥的採用。

炎症性腸病市場報告要點

  • 由於克羅恩病的患病率上升以及治療性生物製劑的高處方率，克羅恩病所佔的份額最大。
  • 由於用於治療潰瘍性結腸炎的生物製劑獲得批准且患者人數眾多，因此潰瘍性結腸炎有望創下最快的增長速度。
  • 由於 IBD 治療的高處方率和消費者對 TNF 抑製劑的認識不斷提高，TNF 抑製劑部分將在 2022 年佔據最大的市場份額。
  • 按給藥途徑劃分，注射劑預計將在 2022 年主導炎症性腸病治療市場，其中口服劑型增長最快。
  • 由於高住院率和有利的報銷範圍，醫院藥房部分在 2022 年成為最大的部分。
  • 由於市場參與者的投資增加以及該地區疾病流行率上升，預計亞太地區在預測期內將呈現最快的增長速度。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法：產品流方法
  • 調查假設
  • 二級信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望
  • 競爭考慮

第 3 章炎症性腸病治療市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場
  • 市場動態
    • 市場驅動因素分析
      • 穩健的產品線
      • 克羅恩病和潰瘍性結腸炎患病率高
      • 不斷增長的老年人口
    • 市場製約因素分析
      • 多項專利到期
      • 昂貴的醫療費用
  • 描繪滲透率和增長前景
  • 胃腸療法：市場分析工具
    • 行業分析 - 搬運工
    • PESTLE 分析
  • 監管框架
  • 價格分析

第 4 章炎症性腸病治療市場細分分析，按類型，2018-2030（百萬美元）

  • 定義和範圍
  • 類型市場份額分析，2022 年和 2030 年
  • 部門儀表板
  • 2018-2030 年按類型分列的全球炎症性腸病治療市場
  • 2018-2030 年市場規模和預測、趨勢分析
    • 克羅恩病
    • 潰瘍性結腸炎

第 5 章炎症性腸病治療市場細分分析（按藥物類別），2018-2030（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年藥物類別市場份額分析
  • 部門儀表板
  • 2018-2030 年按藥物類別劃分的全球炎症性腸病治療市場
  • 2018-2030 年市場規模和預測、趨勢分析
    • 氨基水楊酸
    • 皮質類固醇
    • 腫瘤壞死因子抑製劑
    • IL抑製劑
    • 抗整合素
    • JAK 抑製劑
    • 其他

第 6 章炎症性腸病治療市場細分分析，按給藥途徑，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年行政程序市場份額分析
  • 部門儀表板
  • 按給藥途徑劃分的全球炎症性腸病治療市場，2018-2030 年
  • 2018-2030 年市場規模和預測、趨勢分析
    • 口語
    • 可注射

第 7 章炎症性腸病治療市場細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年分銷渠道市場份額分析
  • 部門儀表板
  • 2018-2030 年全球炎症性腸病治療市場（按分銷渠道）
  • 2018-2030 年市場規模和預測、趨勢分析
    • 醫院藥房
    • 零售藥房
    • 在線藥店

第 8 章炎症性腸病治療市場細分分析，按地區，2018-2030（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場概況
  • SWOT 分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2022-2030 年市場規模、預測、收入和趨勢分析
    • 北美
      • 美國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 加拿大
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 歐洲
      • 英國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 德國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 西班牙
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 法國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 意大利
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 丹麥
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 瑞典
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 挪威
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 亞太地區
      • 日本
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 中國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 印度
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 韓國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 澳大利亞
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 泰國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 新加坡
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 拉丁美洲
      • 巴西
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 墨西哥
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 阿根廷
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 多邊環境協定
      • 南非
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 沙特阿拉伯
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 阿拉伯聯合酋長國
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 科威特
      • 主要國家動態
      • 競爭場景
      • 監管框架
      • 贖回場景

第 9 章炎症性腸病治療市場 - 競爭分析

  • 主要市場進入者的近期趨勢和影響分析
    • Ansov 矩陣
    • 熱圖分析
    • 對主要交易和戰略聯盟的分析
      • 合資企業
      • 許可協議
      • 產品發布
      • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
  • 上市公司
    • 競爭儀錶盤分析
      • 市場差異化因素
  • 私人公司
    • 主要初創公司名單
  • 公司簡介
    • 艾伯維公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 百健
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 武田製藥有限公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 諾華公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 輝瑞公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 莉莉
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • UCB SA
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 強生服務公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CELLTRION INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 默克公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-3-68038-114-6

Inflammatory Bowel Disease Treatment Market Growth & Trends:

The global inflammatory bowel disease treatment market size is expected to reach USD 27.0 billion, expanding at a CAGR of 3.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of the disease, the surge in awareness about inflammatory bowel disease among people, and favorable regulatory scenarios are projected to drive the inflammatory bowel disease treatment market over the forecast period. For instance, in December 2022, Pfizer Inc. announced the U.S. FDA acceptance for review of an NDA for etrasimod for patients having severe ulcerative colitis. The favorable initiatives undertaken by regulatory authorities for treatment designations and approval of novel drugs for the management of inflammatory bowel disease are fueling market expansion.

The increasing collaboration of market players and non-profit organizations to counter various challenges in the development of novel therapeutics for IBD treatment is projected to propel market growth. For instance, in October 2022, Verily, a precision health company and the Crohn's & Colitis Foundation expanded their strategic collaboration to accelerate research in ulcerative colitis and Crohn's disease. In addition, the European Crohn's and Colitis Organization has taken several favorable steps to improve the care of patients living with inflammatory bowel disease.

Recently approved novel drugs such as filgotinib, ozanimod, upadacitinib, and risankizumab for the treatment of inflammatory bowel disease are expected to support market growth in the coming years. Moreover, the regulatory authorities are encouraging manufacturers to develop novel therapeutic approaches for rare and life-threatening diseases. For instance, in December 2020, Thetis Pharmaceuticals received an orphan drug designation for TP-317 from the U.S. FDA for pediatric ulcerative colitis. Such favorable initiatives are expected to boost the R&D activities to develop novel therapeutic products for IBD.

Furthermore, the rising demand & approvals for biosimilars for the treatment of various inflammatory conditions is a high-impact rendering factor for the market. For instance, in December 2022, the U.S. FDA approved Idacio as an eighth adalimumab biosimilar in the U.S. The newly approved biosimilar is a citrate-free low-concentration preparation intended for the treatment of several inflammatory conditions, including CD in adults and children aged 6 years or older. In addition, in October 2021, the U.S. FDA approved Cyltezo for the management of moderate to severe CD and UC. Moreover, the increasing introduction of biosimilars is expected to boost the adoption of biological products for the treatment of IBD in developing economies.

Moreover, government bodies are taking efforts to promote the uptake of biosimilars with their safe use. For instance, in October 2022, the government of Saskatchewan launched a biosimilar initiative to help its residents to access high-quality therapeutics at a lesser cost. Similarly, provinces like Ontario and Quebec in Canada are also expanding biosimilar initiatives to promote the uptake of biosimilar candidates.

Inflammatory Bowel Disease Market Report Highlights:

  • The Crohn's disease segment held the largest share owing to the increasing prevalence of the condition and the high prescription rate of biologics for the treatment of the disease
  • The ulcerative colitis segment is poised to register the fastest growth rate due to the rising approval of biologics for the treatment of ulcerative colitis and the high patient base
  • The TNF inhibitors segment accounted for the largest market share in 2022 owing to the high prescription rate for the treatment of IBD and rising consumer awareness about TNF inhibitors
  • Based on the route of administration, the injectable segment dominated the inflammatory bowel disease treatment market in 2022, whereas the oral segment is anticipated to be the fastest-growing segment
  • The hospital pharmacy segment was the largest in 2022, owing to higher hospitalization rates and favorable reimbursement coverage
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing disease prevalence in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Competitive Insights

Chapter 3 Inflammatory Bowel Disease Treatment Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market
  • 3.2 Market Dynamics
    • 3.2.1 Market drivers analysis
      • 3.2.1.1 Robust product pipeline
      • 3.2.1.2 High prevalence of crohn's disease and ulcerative colitis
      • 3.2.1.3 Increasing geriatric population
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 High number of patent expirations
      • 3.2.2.2 High cost of treatment
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Gastrointestinal Therapeutics: Market Analysis Tools
    • 3.4.1 Industry analysis- Porter's
    • 3.4.2 PESTLE analysis
  • 3.5 Regulatory Framework
  • 3.6 Pricing Analysis

Chapter 4 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Type Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Inflammatory Bowel Disease Treatment Market, by Type, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Crohn's Disease
      • 4.5.1.1 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.2 Ulcerative Colitis
      • 4.5.2.1 Ulcerative colitis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Drug Class 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Drug Class Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Inflammatory Bowel Disease Treatment Market, by Drug Class, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Aminosalicylates
      • 5.5.1.1 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Corticosteroids
      • 5.5.2.1 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.3 TNF inhibitors
      • 5.5.3.1 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.4 IL inhibitors
      • 5.5.4.1 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.5 Anti-integrin
      • 5.5.5.1 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.6 JAK inhibitors
      • 5.5.6.1 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.7 Others
      • 5.5.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Route of Administration, 2018 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 Route of Administration Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Oral
      • 6.5.1.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Injectable
      • 6.5.2.1 Injectable market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 7.1 Definition and Scope
  • 7.2 Distribution Channel Market Share Analysis, 2022 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.5.1 Hospital Pharmacy
      • 7.5.1.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2 Retail Pharmacy
      • 7.5.2.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3 Online Pharmacy
      • 7.5.3.1 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Definition & Scope
  • 8.2 Regional Market Share Analysis, 2022 & 2030
  • 8.3 Regional Market Dashboard
  • 8.4 Regional Market Snapshot
  • 8.5 SWOT Analysis
    • 8.5.1 North America
    • 8.5.2 Europe
    • 8.5.3 Asia Pacific
    • 8.5.4 Latin America
    • 8.5.5 Middle East and Africa
  • 8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
    • 8.6.1 North America
      • 8.6.1.1 North America inflammatory bowel disease treatment market , 2018 - 2030 (USD Million)
      • 8.6.1.2 U.S.
      • 8.6.1.2.1 Key Country Dynamics
      • 8.6.1.2.2 Competitive Scenario
      • 8.6.1.2.3 Regulatory Framework
      • 8.6.1.2.4 Reimbursement Scenario
      • 8.6.1.2.5 U.S. inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.1.3 Canada
      • 8.6.1.3.1 Key Country Dynamics
      • 8.6.1.3.2 Competitive Scenario
      • 8.6.1.3.3 Regulatory Framework
      • 8.6.1.3.4 Reimbursement Scenario
      • 8.6.1.3.5 Canada inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2 Europe
      • 8.6.2.1 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
      • 8.6.2.2 UK
      • 8.6.2.2.1 Key Country Dynamics
      • 8.6.2.2.2 Competitive Scenario
      • 8.6.2.2.3 Regulatory Framework
      • 8.6.2.2.4 Reimbursement Scenario
      • 8.6.2.2.5 UK inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.3 Germany
      • 8.6.2.3.1 Key Country Dynamics
      • 8.6.2.3.2 Competitive Scenario
      • 8.6.2.3.3 Regulatory Framework
      • 8.6.2.23.4 Reimbursement Scenario
      • 8.6.2.3.5 Germany inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.4 Spain
      • 8.6.2.4.1 Key Country Dynamics
      • 8.6.2.4.2 Competitive Scenario
      • 8.6.2.4.3 Regulatory Framework
      • 8.6.2.4.4 Reimbursement Scenario
      • 8.6.2.4.5 Spain inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.5 France
      • 8.6.2.5.1 Key Country Dynamics
      • 8.6.2.5.2 Competitive Scenario
      • 8.6.2.5.3 Regulatory Framework
      • 8.6.2.5.4 Reimbursement Scenario
      • 8.6.2.5.5 France inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.6 Italy
      • 8.6.2.6.1 Key Country Dynamics
      • 8.6.2.6.2 Competitive Scenario
      • 8.6.2.6.3 Regulatory Framework
      • 8.6.2.6.4 Reimbursement Scenario
      • 8.6.2.6.5 Italy inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.7 Denmark
      • 8.6.2.7.1 Key Country Dynamics
      • 8.6.2.7.2 Competitive Scenario
      • 8.6.2.7.3 Regulatory Framework
      • 8.6.2.7.4 Reimbursement Scenario
      • 8.6.2.7.5 Denmark inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.8 Sweden
      • 8.6.2.8.1 Key Country Dynamics
      • 8.6.2.8.2 Competitive Scenario
      • 8.6.2.8.3 Regulatory Framework
      • 8.6.2.8.4 Reimbursement Scenario
      • 8.6.2.8.5 Sweden inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.9 Norway
      • 8.6.2.9.1 Key Country Dynamics
      • 8.6.2.9.2 Competitive Scenario
      • 8.6.2.9.3 Regulatory Framework
      • 8.6.2.9.4 Reimbursement Scenario
      • 8.6.2.9.5 Norway inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Asia Pacific
      • 8.6.3.1 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
      • 8.6.3.2 Japan
      • 8.6.3.2.1 Key Country Dynamics
      • 8.6.3.2.2 Competitive Scenario
      • 8.6.3.2.3 Regulatory Framework
      • 8.6.3.2.4 Reimbursement Scenario
      • 8.6.3.2.5 Japan inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.3 China
      • 8.6.3.3.1 Key Country Dynamics
      • 8.6.3.3.2 Competitive Scenario
      • 8.6.3.3.3 Regulatory Framework
      • 8.6.3.3.4 Reimbursement Scenario
      • 8.6.3.3.5 China inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.4 India
      • 8.6.3.4.1 Key Country Dynamics
      • 8.6.3.4.2 Competitive Scenario
      • 8.6.3.4.3 Regulatory Framework
      • 8.6.3.4.4 Reimbursement Scenario
      • 8.6.3.4.5 India inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.5 South Korea
      • 8.6.3.5.1 Key Country Dynamics
      • 8.6.3.5.2 Competitive Scenario
      • 8.6.3.5.3 Regulatory Framework
      • 8.6.3.5.4 Reimbursement Scenario
      • 8.6.3.25.5 South Korea inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.6 Australia
      • 8.6.3.6.1 Key Country Dynamics
      • 8.6.3.6.2 Competitive Scenario
      • 8.6.3.6.3 Regulatory Framework
      • 8.6.3.6.4 Reimbursement Scenario
      • 8.6.3.6.5 Australia inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.7 Thailand
      • 8.6.3.7.1 Key Country Dynamics
      • 8.6.3.7.2 Competitive Scenario
      • 8.6.3.7.3 Regulatory Framework
      • 8.6.3.7.4 Reimbursement Scenario
      • 8.6.3.7.5 Thailand inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.8 Singapore
      • 8.6.3.8.1 Key Country Dynamics
      • 8.6.3.8.2 Competitive Scenario
      • 8.6.3.8.3 Regulatory Framework
      • 8.6.3.8.4 Reimbursement Scenario
      • 8.6.3.8.5 Thailand inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4 Latin America
      • 8.6.4.1 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
      • 8.6.4.2 Brazil
      • 8.6.4.2.1 Key Country Dynamics
      • 8.6.4.2.2 Competitive Scenario
      • 8.6.4.2.3 Regulatory Framework
      • 8.6.4.2.4 Reimbursement Scenario
      • 8.6.4.2.5 Brazil inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.4.3 Mexico
      • 8.6.4.3.1 Key Country Dynamics
      • 8.6.4.3.2 Competitive Scenario
      • 8.6.4.3.3 Regulatory Framework
      • 8.6.4.3.4 Reimbursement Scenario
      • 8.6.4.3.5 Mexico inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.4.4 Argentina
      • 8.6.4.4.1 Key Country Dynamics
      • 8.6.4.4.2 Competitive Scenario
      • 8.6.4.4.3 Regulatory Framework
      • 8.6.4.4.4 Reimbursement Scenario
      • 8.6.4.4.5 Argentina inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5 MEA
      • 8.6.5.1 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
      • 8.6.5.2 South Africa
      • 8.6.5.2.1 Key Country Dynamics
      • 8.6.5.2.2 Competitive Scenario
      • 8.6.5.2.3 Regulatory Framework
      • 8.6.5.2.4 Reimbursement Scenario
      • 8.6.5.2.5 South Africa inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.5.3 Saudi Arabia
      • 8.6.5.3.1 Key Country Dynamics
      • 8.6.5.3.2 Competitive Scenario
      • 8.6.5.3.3 Regulatory Framework
      • 8.6.5.3.4 Reimbursement Scenario
      • 8.6.5.3.5 Saudi Arabia inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.5.4 UAE
      • 8.6.5.4.1 Key Country Dynamics
      • 8.6.5.4.2 Competitive Scenario
      • 8.6.5.4.3 Regulatory Framework
      • 8.6.5.4.4 Reimbursement Scenario
      • 8.6.5.4.5 UAE inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.5.5 Kuwait
      • 8.6.5.5.1 Key Country Dynamics
      • 8.6.5.5.2 Competitive Scenario
      • 8.6.5.5.3 Regulatory Framework
      • 8.6.5.5.4 Reimbursement Scenario
      • 8.6.5.5.5 Kuwait inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Inflammatory Bowel Disease Treatment Market- Competitive Analysis

  • 9.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 9.1.1 Ansoff matrix
    • 9.1.2 Heat map analysis
    • 9.1.3 Major Deals and Strategic Alliances Analysis
      • 9.1.3.1 Joint Ventures
      • 9.1.3.2 Licensing Agreements
      • 9.1.3.3 Product Launches
      • 9.1.3.4 Conferences and Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
  • 9.3 Vendor Landscape
    • 9.3.1 List of key distributors and channel partners
    • 9.3.2 Key customers
  • 9.4 Public Companies
    • 9.4.1 Competitive Dashboard Analysis
      • 9.4.1.1 Market Differentiators
  • 9.5 Private Companies
    • 9.5.1 List of key emerging companies
  • 9.6 Company Profiles
    • 9.6.1 AbbVie Inc
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.1.4 Strategic Initiatives
    • 9.6.2 Biogen
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic Initiatives
    • 9.6.3 Takeda Pharmaceutical Company Limited
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic Initiatives
    • 9.6.4 Novartis AG
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic Initiatives
    • 9.6.5 Pfizer Inc
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic Initiatives
    • 9.6.6 Lilly
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic Initiatives
    • 9.6.7 UCB S.A.
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 Johnson & Johnson Services, Inc.
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 CELLTRION INC
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 Merck & Co., Inc
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Inflammatory Bowel Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 7 Global Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 Global Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 North America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 North America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 13 North America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 U.S. Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 16 U.S. Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 U.S. Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 Canada Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 20 Canada Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Canada Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 Europe Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 23 Europe Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Europe Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 Europe Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 26 Europe Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 29 Germany Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Germany Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 UK Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 UK Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 UK Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 UK Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 France Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 France Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 37 France Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 France Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Italy Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 Italy Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Italy Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Italy Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Spain Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Spain Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Spain Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Spain Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Denmark Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Denmark Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Denmark Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Sweden Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Sweden Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 Sweden Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 Norway Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 Norway Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 Norway Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 Norway Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Japan Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Japan Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66 Japan Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 Japan Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 China Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 China Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 China Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 China Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 India Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 India Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 74 India Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 India Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 South Korea Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 South Korea Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 78 South Korea Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 South Korea Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Australia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 81 Australia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 82 Australia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 83 Australia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 Singapore Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 85 Singapore Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 86 Singapore Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 Singapore Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 Thailand Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Thailand Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Thailand Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 Thailand Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Latin America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 93 Latin America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 Latin America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Latin America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Latin America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 97 Mexico Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 99 Mexico Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 100 Mexico Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 101 Brazil Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 102 Brazil Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 103 Brazil Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 104 Brazil Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 105 Argentina Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 Argentina Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 107 Argentina Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 Argentina Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 110 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 111 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 112 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 113 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 114 South Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 115 South Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 116 South Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 117 South Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 122 UAE Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 123 UAE Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 124 UAE Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 125 UAE Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 126 Kuwait Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 127 Kuwait Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 128 Kuwait Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 129 Kuwait Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Inflammatory bowel disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2022)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Inflammatory bowel disease treatment market: Type movement analysis
  • Fig. 17 Inflammatory bowel disease treatment market: Type segment dashboard
  • Fig. 18 Inflammatory bowel disease treatment market Type outlook: Key takeaways
  • Fig. 19 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Inflammatory bowel disease treatment market: Drug class movement analysis
  • Fig. 22 Inflammatory bowel disease treatment market: Drug class segment dashboard
  • Fig. 23 Inflammatory bowel disease treatment market Drug class outlook: Key takeaways
  • Fig. 24 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Inflammatory bowel disease treatment market: Route of administration movement analysis
  • Fig. 32 Inflammatory bowel disease treatment market: Route of administration segment dashboard
  • Fig. 33 Inflammatory bowel disease treatment market Route of administration outlook: Key takeaways
  • Fig. 34 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Inflammatory bowel disease treatment market: Distribution channel movement analysis
  • Fig. 37 Inflammatory bowel disease treatment market: Distribution channel segment dashboard
  • Fig. 38 Inflammatory bowel disease treatment market Distribution channel outlook: Key takeaways
  • Fig. 39 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2022 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 Europe, SWOT
  • Fig. 47 Asia Pacific, SWOT
  • Fig. 48 Latin America, SWOT
  • Fig. 49 Middle East and Africa, SWOT
  • Fig. 50 North America
  • Fig. 51 North America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S.
  • Fig. 53 U.S. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Canada
  • Fig. 55 Canada inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 Europe
  • Fig. 57 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 U.K.
  • Fig. 59 U.K. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 Germany
  • Fig. 61 Germany inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 62 Spain
  • Fig. 63 Spain inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 France
  • Fig. 65 France inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Italy
  • Fig. 67 Italy inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Denmark
  • Fig. 69 Denmark inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 Norway
  • Fig. 71 Norway inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 Sweden
  • Fig. 73 Sweden inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific
  • Fig. 75 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan
  • Fig. 77 Japan inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 China
  • Fig. 79 China inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 80 India
  • Fig. 81 India inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea
  • Fig. 83 South Korea inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 84 Australia
  • Fig. 85 Australia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 86 Singapore
  • Fig. 87 Singapore inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand
  • Fig. 89 Thailand inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America
  • Fig. 91 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 92 Brazil
  • Fig. 93 Brazil inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 94 Mexico
  • Fig. 95 Mexico inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 96 Argentina
  • Fig. 97 Argentina inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 98 Middle East and Africa
  • Fig. 99 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 100 South Africa
  • Fig. 101 South Africa inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 102 Saudi Arabia
  • Fig. 103 Saudi Arabia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 104 UAE
  • Fig. 105 UAE inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 106 Kuwait
  • Fig. 107 Kuwait inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 108 Ansoff Matrix
  • Fig. 109 Heat map analysis
  • Fig. 110 Market differentiators